Latest News and Press Releases

STOCKHOLM, Sweden, June 27, 2003 (PRIMEZONE) -- The Board of Directors of Biora resolved to convene an Extraordinary Shareholders' Meeting on Wednesday August 6, 2003 at 1:00 pm at Medeon Science...

STOCKHOLM, Sweden, June 23, 2003 (PRIMEZONE) -- Biora AB has applied for the de-listing of its Ordinary Shares from the Stockholm Stock Exchange (SSE). The last trading day for Biora's Ordinary...

STOCKHOLM, Sweden, June 12, 2003 (PRIMEZONE) -- Straumann AG Holdings ("Straumann") has announced that it has acquired approximately 91 percent of the Ordinary Shares of Biora AB pursuant to its...

STOCKHOLM, Sweden, June 4, 2003 (PRIMEZONE) -- Biora has received U.S. Food and Drug Administration (FDA) approval for a new indication for EmdogainGel in the treatment of mandibular Class II...

STOCKHOLM, Sweden, May 14, 2003 (PRIMEZONE) -- Upon a shareholder request, the Board of Biora AB will publish the fairness opinion prepared by Enskilda Securities in regards to the offer made by...

STOCKHOLM, Sweden, April 29, 2003 (PRIMEZONE) -- At the Annual General Meeting "AGM" in Malmo, Sweden today, six of the ordinary members of the Board of Directors were re-elected. Jan Kvarnstrom,...

STOCKHOLM, Sweden, April 25, 2003 (PRIMEZONE) -- Biora AB (publ): 1st Qtr 1st Qtr Full Year 2003 2002 2002 Net...

STOCKHOLM, Sweden, April 14, 2003 (PRIMEZONE) -- Biora's Board of Directors have decided to release the report for the first quarter 2003 on April 25, 2003. Biora develops manufactures and sells...

STOCKHOLM, Sweden, April 7, 2003 (PRIMEZONE) -- In a press release today, Straumann Holding AG ("Straumann") announced the following public offer to the shareholders of and the holders of warrants...

STOCKHOLM, Sweden, April 4, 2003 (PRIMEZONE) -- Biora AB and Medpharma plc (UK) have reached a settlement concerning their dispute regarding their license agreement for development and...